Biomarin Pharmaceutical Inc. (BMRN) announced a profit for its fourth quarter that increased from the same period last year and beat the Street estimates.
The company's earnings totaled $125 million, or $0.64 per share. This compares with $20 million, or $0.11 per share, last year.
Excluding items, Biomarin Pharmaceutical Inc. reported adjusted earnings of $180 million or $0.92 per share for the period.
Analysts on average had expected the company to earn $0.74 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 15.6% to $747 million from $646 million last year.
Biomarin Pharmaceutical Inc. earnings at a glance (GAAP) :
-Earnings: $125 Mln. vs. $20 Mln. last year.
-EPS: $0.64 vs. $0.11 last year.
-Revenue: $747 Mln vs. $646 Mln last year.
For comments and feedback: editorial@rttnews.com